Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
Fiona Robinson, Consultant, Medical Writing and Editing, at Communications Fiona Robinson, reposted from National Bleeding Disorders Foundation on LinkedIn:
”Rebalancing agents are now a treatment option for some bleeding disorders – but what exactly are rebalancing agents?
What do people with bleeding disorders and their caregivers need to know about them?
In the next National Bleeding Disorders Foundation Wednesday Webinar we will hear from medical, research, and lived experience experts about how they consider this exciting new class of therapeutics in their shared decision-making to choose the best options for their unique needs?
June 3, 2PM ET
Bring your questions for the live QandA!”
Quoting National Bleeding Disorders Foundation‘s post:
”Rebalancing Agents and You: Partnering in Treatment Decisions
Join NBDF and expert clinicians to learn about rebalancing agents, a new class of therapies for bleeding disorders.
This session will help patients and caregivers understand how these treatments work, what to expect, and how to engage in shared decision-making with their care team to choose the best options for their unique needs.”
Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients